Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Head and Neck Cancer

Free Subscription 16.09.2019 1 Am J Gastroenterol 1 Am J Surg 3 Anticancer Res 1 BMC Cancer 4 Cancer 1 Clin Nucl Med 1 Dis Esophagus 1 Gastrointest Endosc 6 Head Neck 4 J Clin Endocrinol Metab 1 J Laryngol Otol 1 J Nucl Med 1 J Oral Maxillofac Surg 1 Surgery 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. WANG Z, Shaheen NJ, Whiteman DC, Anderson LA, et al
   Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
   Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0070.
   PubMed     Text format     Abstract available
   
   

   
   Am J Surg

2. HARBISON GJ, Vossler JD, Yim NH, Murayama KM, et al
   Outcomes of robotic versus non-robotic minimally-invasive esophagectomy for esophageal cancer: An American College of Surgeons NSQIP database analysis.
   Am J Surg. 2019 Aug 26. pii: S0002-9610(19)30353.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

3. KALFERT D, Ludvik J, Kucera R, Topolcan O, et al
   Pretreatment Serum Levels of Soluble Cytokeratin Fragments (Cyfra 21-1, TPS, MonoTotal) in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
   Anticancer Res. 2019;39:5171-5177.
   PubMed     Text format     Abstract available
   
   
4. PARK SR, Yoon DH, Kim JH, Kim YH, et al
   A Randomized Phase III Trial on the Role of Esophagectomy in Complete Responders to Preoperative Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESOPRESSO).
   Anticancer Res. 2019;39:5123-5133.
   PubMed     Text format     Abstract available
   
   
5. LOGANADANE G, Kann BH, Park HS, Johnson SB, et al
   Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy.
   Anticancer Res. 2019;39:4885-4890.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

6. SUN XS, Liang YJ, Liu SL, Chen QY, et al
   Maximal standard uptake values of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
   BMC Cancer. 2019;19:908.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

7. ROCHE AM, Fedewa SA, Shi LL, Chen AY, et al
   Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
   Cancer. 2018 Feb 6. doi: 10.1002/cncr.31252.
   PubMed     Text format     Abstract available
   
   
8. NIKIFOROVA MN, Mercurio S, Wald AI, Barbi de Moura M, et al
   Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
   Cancer. 2018 Jan 18. doi: 10.1002/cncr.31245.
   PubMed     Text format     Abstract available
   
   
9. ARGIRION I, Zarins KR, Ruterbusch JJ, Vatanasapt P, et al
   Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.
   Cancer. 2019 Sep 16. doi: 10.1002/cncr.32517.
   PubMed     Text format     Abstract available
   
   
10. WIRTH LJ, Tahara M, Robinson B, Francis S, et al
    Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
    Cancer. 2018 Apr 14. doi: 10.1002/cncr.31344.
    PubMed     Text format     Abstract available
    
    

    
    Clin Nucl Med

11. KESIM S, Ones T, Ozguven S, Dulundu E, et al
    Selective Internal Radiation Therapy for Liver Metastasis of Papillary Thyroid Carcinoma.
    Clin Nucl Med. 2019 Sep 12. doi: 10.1097/RLU.0000000000002763.
    PubMed     Text format     Abstract available
    
    

    
    Dis Esophagus

12. JIANG W, Verma V, Haque W, Moreno AC, et al
    Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer.
    Dis Esophagus. 2019 Aug 28. pii: 5555765. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Gastrointest Endosc

13. DE GROOF AJ, Swager AF, Pouw RE, Weusten BLAM, et al
    Blue-light imaging has an additional value to white-light endoscopy in visualization of early Barrett's neoplasia: an international multicenter cohort study.
    Gastrointest Endosc. 2019;89:749-758.
    PubMed     Text format     Abstract available
    
    

    
    Head Neck

14. TAM S, Nurgalieva Z, Weber RS, Lewis CM, et al
    Adherence with National Comprehensive Cancer Network posttreatment surveillance guidelines in patients with head and neck cancer.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25936.
    PubMed     Text format     Abstract available
    
    
15. GIRKAR F, Thiagarajan S, Malik A, Sawhney S, et al
    Factors predisposing to the development of orocutaneous fistula following surgery for oral cancer: Experience from a tertiary cancer center.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25951.
    PubMed     Text format     Abstract available
    
    
16. MOWERY AJ, Conlin MJ, Clayburgh DR
    Elevated incidence of head and neck cancer in solid organ transplant recipients.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25937.
    PubMed     Text format     Abstract available
    
    
17. WU L, Zhuo S, Zeng W, Liang S, et al
    Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.
    Head Neck. 2019 Sep 13. doi: 10.1002/hed.25953.
    PubMed     Text format     Abstract available
    
    
18. RODEN D, Daniels K, Metkus J, Goldman R, et al
    Evaluation of oncologic outcomes in head and neck cancer patients >/=80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25950.
    PubMed     Text format     Abstract available
    
    
19. HAN JE, Yi SK, Wang S, Erman A, et al
    Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.
    Head Neck. 2019 Sep 14. doi: 10.1002/hed.25955.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Endocrinol Metab

20. BOUCAI L, Falcone J, Ukena J, Coombs CC, et al
    Radioactive iodine-related clonal hematopoiesis in thyroid cancer is common and associated with decreased survival.
    J Clin Endocrinol Metab. 2018 Aug 17. pii: 5075165. doi: 10.1210/jc.2018-00803.
    PubMed     Text format     Abstract available
    
    
21. HWANGBO Y, Lee EK, Son HY, Im SW, et al
    Genome-wide Association Study Reveals Distinct Genetic Susceptibility of Thyroid Nodules from Thyroid Cancer.
    J Clin Endocrinol Metab. 2018 Aug 6. pii: 5066513. doi: 10.1210/jc.2017-02439.
    PubMed     Text format     Abstract available
    
    
22. KIM K, Kim IJ, Pak K, Kim SJ, et al
    Evaluation of bone mineral density using DXA and central QCT in postmenopausal patients under thyrotropin suppressive therapy.
    J Clin Endocrinol Metab. 2018 Jun 21. pii: 5041930. doi: 10.1210/jc.2017-02704.
    PubMed     Text format     Abstract available
    
    
23. LOVEDAY C, Josephs K, Chubb D, Gunning A, et al
    p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer.
    J Clin Endocrinol Metab. 2018 Mar 23. pii: 4951497. doi: 10.1210/jc.2017-02529.
    PubMed     Text format     Abstract available
    
    

    
    J Laryngol Otol

24. IQBAL MS, Wilkinson D, Tin A, Bossi P, et al
    Cetuximab in the management of nasopharyngeal carcinoma - a narrative review.
    J Laryngol Otol. 2019 Sep 11:1-13. doi: 10.1017/S0022215119001853.
    PubMed     Text format     Abstract available
    
    

    
    J Nucl Med

25. ROTTENBURGER C, Nicolas GP, McDougall L, Kaul F, et al
    Cholecystokinin-2 Receptor Agonist (177)Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma - Results of the Lumed Phase 0a Study.
    J Nucl Med. 2019 Sep 13. pii: jnumed.119.233031. doi: 10.2967/jnumed.119.233031.
    PubMed     Text format     Abstract available
    
    

    
    J Oral Maxillofac Surg

26. HOJVIG JH, Kehlet H, Bonde CT
    Enhanced Recovery After Head and Neck Cancer Reconstruction With a Free Flap-What Is Next?
    J Oral Maxillofac Surg. 2019 Aug 20. pii: S0278-2391(19)31031.
    PubMed     Text format    
    
    

    
    Surgery

27. HARRIES V, Wang LY, McGill M, Xu B, et al
    Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?
    Surgery. 2019 Sep 9. pii: S0039-6060(19)30512-4. doi: 10.1016/j.surg.2019.
    PubMed     Text format     Abstract available
    
    

    
    Thyroid

28. ULLMANN TM, Gray KD, Limberg J, Stefanova D, et al
    Insurance Status Affects Extent of Treatment for Patients with Papillary Thyroid Carcinoma.
    Thyroid. 2019 Sep 10. doi: 10.1089/thy.2019.0245.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: